The EU-funded COST network on Imprinting Disorders wishes to develop a new EMQN scheme for Beckwith-Wiedemann and Russel-Silver syndromes. To establish the status quo, the COST network would like to get a better unterstanding of what imprinting disorders labs are testing, and the methods used.
If you test for these disorders, please consider completing the short online survey which can be accessed using this link: http://www.surveymonkey.com/s/6YXDGDM
Alternatively, please contact Deborah Mackay (DJGM(at)soton.ac.uk) or Karen Gronskov (Karen.Groenskov(at)regionh.dk) on behalf of Prof. Thomas Eggermann, chair of the grant (teggermann(at)ukaachen.de).
EMQN Newletter October 2013 (pdf)
Mit der Gründung des Netzwerks EUCID.net ist es Aachener Wissenschaftlern um Professor Thomas Eggermann am Institut für Humangenetik der Uniklinik RWTH Aachen gelungen, eine europäische Plattform zur Erforschung einer Gruppe von angeborenen Imprinting-Erkrankungen aufzubauen.
Zum Artikel bei Grenzecho.net
Cost Action representing European network for congenital Imprinting calls for partners to join them.
COST Action, BM1208, represents the recently established European network for congenital Imprinting disorders. This action currently includes more than 30 groups from 12 European countries (clinicians, geneticists, molecular biologists, patients organisations, SME), aiming on standardisation of treatment and diagnosis of Imprinting disorders (e.g. Prader-Willi, Angelman syndrome), on networking research and dissemination of findings. A specific website for the Network (http://www.imprinting-disorders.eu) is currently under construction. This is a growing network and is expecting more groups from 10 European countries (and non-European partners) to participate.
An interview with the Chair for a new COST Action, BM1208, Dr. Thomas Eggerman enlightens us with more information on the European network for Congenital Imprinting.
Read the entire interview here